Lannett Co Inc (LCI) Position Held by First Quadrant L P CA
First Quadrant L P CA held its stake in shares of Lannett Co Inc (NYSE:LCI) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 20,200 shares of the company’s stock at the end of the second quarter. First Quadrant L P CA owned about 0.05% of Lannett Co worth $412,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. State of Alaska Department of Revenue boosted its stake in shares of Lannett Co by 77.6% in the second quarter. State of Alaska Department of Revenue now owns 5,753 shares of the company’s stock valued at $117,000 after buying an additional 2,513 shares during the last quarter. Mason Street Advisors LLC boosted its stake in shares of Lannett Co by 7.5% in the first quarter. Mason Street Advisors LLC now owns 6,870 shares of the company’s stock valued at $154,000 after buying an additional 482 shares during the last quarter. Airain ltd purchased a new stake in shares of Lannett Co during the first quarter valued at $205,000. Neuberger Berman Group LLC purchased a new stake in shares of Lannett Co during the first quarter valued at $209,000. Finally, Cutter & CO Brokerage Inc. purchased a new stake in shares of Lannett Co during the first quarter valued at $255,000. 95.14% of the stock is owned by institutional investors and hedge funds.
Get Lannett Co Inc alerts:
Shares of Lannett Co Inc (NYSE:LCI) traded down 1.22% on Thursday, reaching $16.15. 514,567 shares of the company were exchanged. Lannett Co Inc has a 52 week low of $16.05 and a 52 week high of $39.99. The company’s market capitalization is $601.26 million. The company’s 50-day moving average is $20.21 and its 200-day moving average is $21.35.
WARNING: “Lannett Co Inc (LCI) Position Held by First Quadrant L P CA” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://www.com-unik.info/2017/08/10/lannett-co-inc-lci-position-maintained-by-first-quadrant-l-p-ca-updated.html.
LCI has been the subject of several analyst reports. Roth Capital set a $27.00 price target on shares of Lannett Co and gave the company a “buy” rating in a research report on Tuesday, May 2nd. Zacks Investment Research raised shares of Lannett Co from a “hold” rating to a “buy” rating and set a $27.00 target price for the company in a research report on Saturday, April 22nd. BidaskClub cut shares of Lannett Co from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Deutsche Bank AG reaffirmed a “hold” rating and issued a $23.00 target price (up from $22.00) on shares of Lannett Co in a research report on Monday, July 17th. Finally, Oppenheimer Holdings, Inc. reaffirmed a “hold” rating on shares of Lannett Co in a research report on Thursday, June 8th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $27.50.
Lannett Co Company Profile
Lannett Company, Inc develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.
What are top analysts saying about Lannett Co Inc? – Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Lannett Co Inc and related companies.